Stock listing

Turquoise:CINPAS Cinclus Pharma Holding AB Share Price

UK listing (Turquoise) of Cinclus Pharma Holding AB · home listing Stockholm:CINPHA

Follow Cinclus Pharma Holding AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:CINPHA

11.22 SEK -0.12 (-1.1%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:CINPHA

Past year -35.7% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
11.00 – 11.38 SEKNov 20, 2026
Volume
46,511 sharesNov 20, 2026
Market cap
522.2M SEKAt the close on Nov 20, 2026 · price × 46.54M shares outstanding
52-week range
10.48 – 19.64 SEKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
643,125 SEKMedian day 36,033 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Cinclus Pharma Holding AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:CINPHA · Home11.22 SEK-0.12 (-1.1%)46,51111.3811.3811.0011.34Close on Nov 20, 2026
Frankfurt:J8P€0.969 EUR+0.002 (+0.2%)—€0.969€0.969€0.969€0.967Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXSTO:CINPHA · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
11.22-0.12-1.1%11.3811.3811.0046,511
11.34-0.18-1.6%11.5011.6611.3435,870
11.52-0.06-0.5%12.2612.2611.4025,023
11.580.000.0%11.7611.7611.4034,683
11.58+0.16+1.4%11.4811.7811.4827,009
11.42-0.24-2.1%11.7011.8211.2043,753
11.66-0.42-3.5%12.2012.2011.58106,432
12.08+0.58+5.0%11.8412.1411.2093,216
11.50+0.34+3.0%11.1611.8411.1616,495
11.16-0.24-2.1%11.4811.4811.1624,382
11.40-0.24-2.1%11.6611.6811.409,981
11.64-0.34-2.8%11.9611.9611.5052,488
11.98-0.02-0.2%11.9812.0011.809,876
12.00+0.30+2.6%11.9012.1211.7260,843
11.70-0.26-2.2%11.7412.2611.6629,534
11.96-0.04-0.3%11.8812.1611.7034,316
12.00+0.26+2.2%11.8012.0011.7235,004
11.74-0.10-0.8%12.3612.3611.6832,523
11.84-0.62-5.0%12.3812.4611.8447,871
12.46-0.30-2.4%12.7612.7812.3819,267
12.76+0.24+1.9%12.5212.8412.3616,713
12.52-0.12-0.9%12.7812.7812.3618,282
12.64-0.54-4.1%12.7813.0012.6411,241
13.18+0.24+1.9%12.9613.5012.5230,006
12.94+0.26+2.1%12.7013.0412.7065,423
12.68-0.08-0.6%12.8012.9812.6620,082
12.76-0.44-3.3%13.2013.2812.7076,153
13.20-0.26-1.9%13.1413.4413.1020,703
13.46+0.18+1.4%13.3213.5013.0457,369
13.28-0.18-1.3%13.2013.5013.1025,250
13.46-0.06-0.4%13.5013.5213.0868,014
13.52+0.58+4.5%12.8813.8012.80104,615
12.94-0.32-2.4%13.5013.9812.9298,492
13.26+0.06+0.5%13.4613.8013.0071,939
13.20+0.60+4.8%12.6013.4012.6093,830
12.60+0.64+5.4%12.0012.6611.88107,486
11.96+0.14+1.2%11.8212.2011.7834,126
11.82+0.32+2.8%11.5611.8811.4429,551
11.50-0.24-2.0%11.8811.8811.1037,289
11.74-0.02-0.2%11.6811.8811.5215,171
11.76-0.08-0.7%11.8412.0011.5826,588
11.84+0.34+3.0%11.4412.0811.2074,164
11.50-0.04-0.3%11.4012.0811.4043,797
11.54-0.06-0.5%11.6011.8211.2026,667
11.60-0.28-2.4%11.8812.0011.588,118
11.88+0.02+0.2%12.0012.1211.5031,236
11.86-0.48-3.9%12.3212.3211.8454,210
12.34-0.14-1.1%12.4012.5011.9816,639
12.48-0.12-1.0%12.3012.4812.1015,511
12.60-0.04-0.3%12.6212.6612.2613,270
12.64+0.06+0.5%12.5813.0012.3892,259
12.58-0.04-0.3%12.5012.7612.4028,030
12.62+0.20+1.6%12.4012.7012.4079,485
12.42+0.22+1.8%12.3812.8012.2236,196
12.20-1.34-9.9%14.2414.3012.00275,497
13.54-0.46-3.3%14.0014.0813.28142,529
14.000.000.0%14.0814.1413.4247,476
14.000.000.0%14.0014.4213.8838,251
14.00+0.04+0.3%13.7614.2013.7660,606
13.96+0.26+1.9%13.5214.1413.4868,902
13.70+0.50+3.8%13.3414.0013.2485,517
13.200.000.0%13.1213.3813.1234,820
13.20+0.10+0.8%13.1013.8013.0868,773
13.10+1.22+10.3%12.0213.4811.90116,418
Ticker
Turquoise:CINPAS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Turquoise
Currency
SEK

What changed lately

Latest news

All Cinclus Pharma Holding AB news

Cinclus Pharma Holding AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in the last 12 months · 1 in all · newest Mar 13, 2026 · oldest 2026
Decks
3 decks · latest Aug 20, 2025

Where Cinclus Pharma Holding AB is listed

ListingExchangeCountryCurrency
Stockholm:CINPHA · Home listingStockholmSwedenSEK
LS Exchange:A3EN5GLS ExchangeGermanyEUR
gettex:J8PgettexGermanyEUR
Munich:J8PMunichGermanyEUR
Turquoise:CINPAS · This pageTurquoiseUnited KingdomSEK
Frankfurt:J8PFrankfurtGermanyEUR
Lang & Schwarz:A3EN5GLang & SchwarzGermanyEUR
Stuttgart:J8PStuttgartGermanyEUR

Valuation

EV/sales 3.8× against a median of 8.6×: 3rd lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
134.2M SEK
P/E
Loss
EV/sales
3.8×
EV/EBITDA
Negative EBITDA
Price/book
2.6×
Gross margin
Not reported
Operating margin
−830.1%
Net margin
−765.8%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Cinclus Pharma Holding AB · OMXSTO:CINPHAUS$51.13MUS$13.15Mn/a3.8×n/a2.6×−765.8%0.0×n/a
Xilio Therapeutics, Inc. · NASDAQ:XLOUS$53.40M−US$62.82Mn/a−1.1×n/a0.8×−20.9%0.1×0.76
Impact BioMedical, Inc. · AMEX:IBOUS$53.31MUS$53.29M33.0×1,402×n/a5.3×n/a0.0×0.06
XBiotech Inc. · NASDAQ:XBITUS$52.74M−US$52.29Mn/an/an/a0.4×n/a0.0×0.52
Bonus Biogroup Ltd. · TASE:BONSUS$52.22MUS$54.52Mn/an/an/an/an/an/an/a
iBio, Inc. · NASDAQ:IBIOUS$51.45M−US$23.13Mn/a−21.5×n/a0.7×n/a0.0×2.01
Sirnaomics Ltd. · HKEX:2257US$51.13MUS$69.20Mn/an/an/an/an/an/an/a
Aldeyra Therapeutics, Inc. · NASDAQ:ALDXUS$50.70MUS$9.72Mn/an/an/a1.4×n/a0.0×0.66
Clene Inc. · NASDAQ:CLNNUS$50.69MUS$58.31Mn/a245×n/an/an/an/a1.48
Acrivon Therapeutics, Inc. · NASDAQ:ACRVUS$49.35M−US$26.60Mn/an/an/a0.7×n/a0.0×2.09
Aptamer Sciences, Inc. · KRX:291650US$49.20MUS$34.45Mn/a8.6×n/a1.6×−215.8%0.0×n/a
Median of the othersUS$51.29MUS$22.09M33.0×8.6×0.8×−118.3%0.0×0.76

Forecasts

Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
45.00 SEK · Analysts' mean
EPS, year to Dec 2026
-6.03 · 2 analysts
Revenue, year to Dec 2026
85.93M · 4 analysts

Team and board

Officers

OfficerRole
Christer AhlbergChief Executive Officer and President
Magnus ChristensenChief Financial Officer
Henrik VikströmIR
Jesper WiklundChief Business Officer
Kajsa LarssonChief Medical Officer
Lennart HanssonChairman of the Board, Co-founder
Peter WallichCommercial Director

Board

DirectorRole
Lennart HanssonChairman of the Board, Co-founder
Anders LundströmNon-executive Director
David ArmstrongNon-executive Director
Fredrik JohanssonNon-executive Director
Helena LevanderNon-executive Director
Torbjörn KoivistoNon-executive Director
Wenche RolfsenNon-executive Director

Events

QuarterResultsShare move
Q1 2025May 20, 2025 · Before open+6.5%
Q4 2024Feb 20, 2025 · Before open−8.1%
Quarter to Sep 30, 2024Nov 14, 2024 · Before open−6.3%
Quarter to Jun 30, 2024Aug 29, 2024 · Before open0.0%

Open Events

Decks

DeckKindSlidesDate
Q2 2025 Earnings PresentationEarnings13 slidesAug 20, 2025
Q3 2024 Earnings PresentationEarnings29 slidesNov 14, 2024
Q2 2024 Earnings PresentationEarnings16 slidesAug 29, 2024

Open Decks

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022
Revenue57.5M4.58M5.96M10.6M
Research and development198.4M136.7M166.7M157.2M
Selling, general and administrative57.2M36.9M39.6M64.1M
Operating income-199.6M-169.6M-201.0M-210.7M
Depreciation and amortization2.38M1.34M1.25M1.11M
EBITDA-197.2M-168.3M-199.7M-209.6M
Interest expense13.9M28.1M17.2M76.0K
Income before tax-183.7M-167.3M-214.6M-231.0M
Net income-184.0M-168.0M-215.1M-249.1M
Earnings per share, basic-3.95-4.54-8.20-5.35
Earnings per share, diluted-3.95-4.54-8.20

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents487.3M566.7M88.0M173.5M
Receivables16.1M0
Current assets536.9M600.5M94.1M184.9M
Total assets546.6M601.0M94.4M185.8M
Accounts payable48.5M18.9M16.4M16.9M
Current liabilities136.8M45.5M164.4M46.1M
Total liabilities177.2M45.7M171.2M58.9M
Shareholders' equity369.4M555.3M-76.8M126.9M
Shares outstanding46.5M46.5M46.5M46.5M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-74.6M-178.4M-209.2M-192.1M
Capital spending-1.13M000
Free cash flow-75.8M-178.4M-209.2M-192.1M
Cash from investing-1.43M0
Cash from financing-1.76M655.2M122.9M
Change in cash-77.8M476.8M-86.3M34.1M

Open Financials

Cap table

Built by 6ix from Cinclus Pharma Holding AB’s releases

Common shares
46,537,789
Fully diluted
46,537,789

Fully diluted

LineShares
Common shares46,537,789

Share count over time

CountShares
Nov 22, 202646,537,789

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Magnus Christensen
Chief Financial Officer (CFO)
Buy5,000SEK 11.58SEK 57,900Nov 12, 2026
Gösta Hiller
Other senior executive
Buy1,000SEK 12.38SEK 12,380Jun 8, 2026
Gösta Hiller
Other senior executive
Buy2,000SEK 12.14SEK 24,280Jun 5, 2026
Kajsa Anna Margareta Larsson
Other member of the company's administrative, management or supervisory body
Buy13,000SEK 12.10SEK 157KJun 4, 2026
Magnus Christensen
Chief Financial Officer (CFO)
Buy7,000SEK 12.18SEK 85,260May 15, 2026
Magnus Christensen
Chief Financial Officer (CFO)
Buy6,500SEK 16.10SEK 105KApr 7, 2026
Jesper Paul Fredrik Wiklund
Closely associated with Jesper Wiklund (Other member of the company's administrative, management or supervisory body)
Buy6,000SEK 17.97SEK 108KMar 20, 2026
Jesper Paul Fredrik Wiklund
Closely associated with Jesper Wiklund (Other member of the company's administrative, management or supervisory body)
Buy5,600SEK 18.40SEK 103KMar 19, 2026
Christer Ahlberg
Chief Executive Officer (CEO)/Managing Directory
Buy29,000SEK 17.13SEK 497KDec 11, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anders LundströmNon-executive Director · Since at least Nov 5, 2026
Christer AhlbergChief Executive Officer and President · Since at least Mar 13, 2026
David ArmstrongNon-executive Director · Since at least Nov 5, 2026
Fredrik JohanssonNon-executive Director · Since at least Nov 5, 2026
Helena LevanderNon-executive Director · Since at least Nov 5, 2026
Henrik VikströmIR · Since at least Mar 13, 2026
Jesper WiklundChief Business Officer · Since at least Nov 5, 2026
Kajsa LarssonChief Medical Officer · Since at least Nov 5, 2026
Lennart HanssonChairman of the Board, Co-founder · Since at least Nov 5, 2026
Magnus ChristensenChief Financial Officer · Since at least Nov 5, 2026
All 13 people
PersonSeat
Peter WallichCommercial Director · Since at least Nov 5, 2026
Torbjörn KoivistoNon-executive Director · Since at least Nov 5, 2026
Wenche RolfsenNon-executive Director · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Cinclus Pharma Holding AB.